TRADES
Latest Trades
FUND
DATE
ACTION
TICKER
COMPANY
SHARES
% of ETF
ARKG 25 Nov 2022 Sell SGFY SIGNIFY HEALTH INC 17,500 0.0221
ARKG 25 Nov 2022 Sell ONVO ORGANOVO HOLDINGS INC 1,856 0.0001
ARKK 25 Nov 2022 Sell MTLS MATERIALISE NV 17,136 0.0022
ARKQ 25 Nov 2022 Sell ONVO ORGANOVO HOLDINGS INC 862 0.0001
ARKX 25 Nov 2022 Buy MYNA MYNARIC AG 12,347 0.0211
ARKK 23 Nov 2022 Sell MTLS MATERIALISE NV 24,320 0.0032
ARKF 22 Nov 2022 Sell MELI MERCADOLIBRE INC 812 0.1052
ARKG 22 Nov 2022 Buy PRME PRIME MEDICINE INC 23,313 0.0183
ARKG 22 Nov 2022 Sell SGFY SIGNIFY HEALTH INC 5,000 0.0062
ARKG 22 Nov 2022 Sell ONVO ORGANOVO HOLDINGS INC 1,239 0.0001
ARKK 22 Nov 2022 Sell MTLS MATERIALISE NV 14,772 0.0019
ARKQ 22 Nov 2022 Sell ONVO ORGANOVO HOLDINGS INC 575 0.0001
ARKX 22 Nov 2022 Buy MYNA MYNARIC AG 17,500 0.0304
ARKG 21 Nov 2022 Buy DNA GINKGO BIOWORKS HOLDINGS INC 3,031,443 0.2683
ARKG 21 Nov 2022 Buy QSI QUANTUM 563,250 0.0705
ARKG 21 Nov 2022 Sell VRTX VERTEX PHARMACEUTICALS INC 4,394 0.0592
ARKG 21 Nov 2022 Buy PRME PRIME MEDICINE INC 31,654 0.0242
ARKG 21 Nov 2022 Sell SGFY SIGNIFY HEALTH INC 15,000 0.0183
ARKG 21 Nov 2022 Sell IOVA IOVANCE BIOTHERAPEUTICS INC 14,014 0.0039
ARKG 21 Nov 2022 Sell ONVO ORGANOVO HOLDINGS INC 68 0.0000
ARKK 21 Nov 2022 Buy DNA GINKGO BIOWORKS HOLDINGS INC 3,984,961 0.1080
ARKK 21 Nov 2022 Sell NVDA NVIDIA CORP 34,857 0.0696
ARKQ 21 Nov 2022 Buy VUZI VUZIX CORP 168,645 0.0838
ARKQ 21 Nov 2022 Sell ONVO ORGANOVO HOLDINGS INC 31 0.0000
ARKW 21 Nov 2022 Buy GBTC BITCOIN INVESTMENT TRUST 176,945 0.1293
ARKW 21 Nov 2022 Sell VCYT VERACYTE INC 32,892 0.0761
ARKF 18 Nov 2022 Sell MELI MERCADOLIBRE INC 2,016 0.2477
ARKF 18 Nov 2022 Buy SI SILVERGATE CAPITAL CORP 74,896 0.2447
ARKF 18 Nov 2022 Sell HOOD ROBINHOOD MARKETS INC 124,070 0.1478
ARKF 18 Nov 2022 Buy COIN COINBASE GLOBAL INC 24,989 0.1465
ARKG 18 Nov 2022 Sell VRTX VERTEX PHARMACEUTICALS INC 10,337 0.1372
ARKG 18 Nov 2022 Sell IOVA IOVANCE BIOTHERAPEUTICS INC 458,104 0.1241
ARKG 18 Nov 2022 Buy DNA GINKGO BIOWORKS HOLDINGS INC 1,026,053 0.0933
ARKG 18 Nov 2022 Buy QSI QUANTUM 13,727 0.0017
ARKK 18 Nov 2022 Sell NVDA NVIDIA CORP 93,397 0.1827
ARKK 18 Nov 2022 Buy COIN COINBASE GLOBAL INC 255,249 0.1480
ARKK 18 Nov 2022 Buy DNA GINKGO BIOWORKS HOLDINGS INC 1,310,879 0.0358
ARKQ 18 Nov 2022 Buy SSYS STRATASYS LTD 55,691 0.0861
ARKQ 18 Nov 2022 Buy VUZI VUZIX CORP 54,624 0.0277
ARKW 18 Nov 2022 Sell SPOT SPOTIFY TECHNOLOGY SA 21,835 0.1466
ARKW 18 Nov 2022 Buy COIN COINBASE GLOBAL INC 36,942 0.1463
ARKW 18 Nov 2022 Sell VCYT VERACYTE INC 481 0.0012
ARKX 18 Nov 2022 Buy BLDE BLADE AIR MOBILITY INC 66,208 0.1145
ARKX 18 Nov 2022 Buy SSYS STRATASYS LTD 21,541 0.1099
ARKX 18 Nov 2022 Buy MYNA MYNARIC AG 26,094 0.0430
ARKG 17 Nov 2022 Sell VRTX VERTEX PHARMACEUTICALS INC 10,117 0.1300
ARKG 17 Nov 2022 Buy DNA GINKGO BIOWORKS HOLDINGS INC 1,291,724 0.1120
ARKG 17 Nov 2022 Sell SGFY SIGNIFY HEALTH INC 80,000 0.0945
ARKG 17 Nov 2022 Sell ONVO ORGANOVO HOLDINGS INC 2,467 0.0002
ARKK 17 Nov 2022 Sell NVDA NVIDIA CORP 41,917 0.0828
ARKK 17 Nov 2022 Buy DNA GINKGO BIOWORKS HOLDINGS INC 1,725,887 0.0451
ARKK 17 Nov 2022 Sell MTLS MATERIALISE NV 9,439 0.0012
ARKQ 17 Nov 2022 Sell PRLB PROTO LABS INC 115,949 0.2927
ARKQ 17 Nov 2022 Sell ESLT ELBIT SYSTEMS LTD 1,109 0.0233
ARKQ 17 Nov 2022 Buy VUZI VUZIX CORP 25,775 0.0125
ARKQ 17 Nov 2022 Buy SSYS STRATASYS LTD 576 0.0009
ARKQ 17 Nov 2022 Sell ONVO ORGANOVO HOLDINGS INC 1,146 0.0002
ARKW 17 Nov 2022 Sell VCYT VERACYTE INC 15,992 0.0368
ARKX 17 Nov 2022 Buy BLDE BLADE AIR MOBILITY INC 13,868 0.0240
ARKX 17 Nov 2022 Buy MYNA MYNARIC AG 11,689 0.0195
ARKX 17 Nov 2022 Buy SSYS STRATASYS LTD 224 0.0011
ARKF 16 Nov 2022 Sell MELI MERCADOLIBRE INC 6,059 0.7135
ARKF 16 Nov 2022 Buy SI SILVERGATE CAPITAL CORP 140,877 0.5214
ARKF 16 Nov 2022 Buy COIN COINBASE GLOBAL INC 81,950 0.4857
ARKF 16 Nov 2022 Sell ICE INTERCONTINENTAL EXCHANGE IN 18,943 0.2375
ARKG 16 Nov 2022 Sell SGFY SIGNIFY HEALTH INC 64,502 0.0737
ARKK 16 Nov 2022 Buy COIN COINBASE GLOBAL INC 163,672 0.0961
ARKK 16 Nov 2022 Sell MTLS MATERIALISE NV 1,528 0.0002
ARKQ 16 Nov 2022 Buy TSLA TESLA INC 3,861 0.0770
ARKQ 16 Nov 2022 Sell PRLB PROTO LABS INC 12,130 0.0296
ARKQ 16 Nov 2022 Sell ESLT ELBIT SYSTEMS LTD 1,345 0.0272
ARKQ 16 Nov 2022 Buy SSYS STRATASYS LTD 72 0.0001
ARKW 16 Nov 2022 Sell VCYT VERACYTE INC 5,549 0.0126
ARKX 16 Nov 2022 Buy VLD VELO3D INC 77,872 0.0699
ARKX 16 Nov 2022 Buy MYNA MYNARIC AG 600 0.0010
ARKX 16 Nov 2022 Buy SSYS STRATASYS LTD 28 0.0001
ARKF 15 Nov 2022 Sell SE SEA LTD 100 0.0008
ARKG 15 Nov 2022 Sell SGFY SIGNIFY HEALTH INC 84,866 0.0972
ARKG 15 Nov 2022 Buy MASS 908 DEVICES INC 45,601 0.0218
ARKG 15 Nov 2022 Buy TWST TWIST BIOSCIENCE CORP 16,974 0.0197
ARKG 15 Nov 2022 Sell ONVO ORGANOVO HOLDINGS INC 5,185 0.0003
ARKK 15 Nov 2022 Buy TWST TWIST BIOSCIENCE CORP 27,596 0.0099
ARKK 15 Nov 2022 Sell MTLS MATERIALISE NV 9,913 0.0013
ARKK 15 Nov 2022 Sell TSP TUSIMPLE HOLDINGS INC 739 0.0000
ARKQ 15 Nov 2022 Sell AVAV AEROVIRONMENT INC 16,918 0.1707
ARKQ 15 Nov 2022 Sell PRLB PROTO LABS INC 42,900 0.1109
ARKQ 15 Nov 2022 Buy XPEV XPENG INC 105,443 0.1026
ARKQ 15 Nov 2022 Buy TSLA TESLA INC 4,000 0.0844
ARKQ 15 Nov 2022 Buy SSYS STRATASYS LTD 18,474 0.0282
ARKQ 15 Nov 2022 Sell ESLT ELBIT SYSTEMS LTD 304 0.0063
ARKQ 15 Nov 2022 Sell ONVO ORGANOVO HOLDINGS INC 2,435 0.0004
ARKQ 15 Nov 2022 Sell TSP TUSIMPLE HOLDINGS INC 61 0.0000
ARKW 15 Nov 2022 Sell HOOD ROBINHOOD MARKETS INC 285,552 0.2463
ARKW 15 Nov 2022 Buy GBTC BITCOIN INVESTMENT TRUST 273,327 0.2211
ARKW 15 Nov 2022 Sell VCYT VERACYTE INC 20,082 0.0512
ARKX 15 Nov 2022 Buy MYNA MYNARIC AG 44,450 0.0753
ARKX 15 Nov 2022 Buy SSYS STRATASYS LTD 6,126 0.0310
ARKX 15 Nov 2022 Buy VLD VELO3D INC 26,111 0.0263
ARKF 14 Nov 2022 Sell SE SEA LTD 586 0.0033
ARKG 14 Nov 2022 Buy MASS 908 DEVICES INC 173,832 0.0863
Latest Blogs
ARK by Cathie Wood is still suffering a year after its apex.

Cathie Wood's flagship exchange-traded fund hit an all-time high in February of this year. Her preferred disruptive-tech chasing strategy may still be in for a lot of suffering after a year and a 53 percent fall.

After a dramatic decline last month, the ARK Innovation ETF (ticker: ARKK) has steadied off - it's practically flat in February – but the headwinds surrounding its speculative growth picks are just becoming more vital. Many businesses that thrived during the pandemic are being hammered by the economic reopening, not only because yields are rising as investors prepare for the US Federal Reserve to raise interest rates, which is terrible news for unprofitable businesses, but also because the economic reopening is hammering many of the businesses that thrived during the pandemic.

Roku, Teladoc, and Zoom, all winners in the work-from-home era, have had their stock prices plummet by as much as 74% in the past year.

Short bets against ARK, according to IHS Markit data, hit a fresh high of 11.4 percent of outstanding shares this week. The Tuttle Capital Short Innovation ETF (SARK), which beats the ARK, now has assets worth more than $US300 million ($416 million).

"Those equities are supported by speculation, and speculation pays less well when the Fed raises rates," said Brent Schutte, chief investment strategist at Northwestern Mutual Wealth Management Co. "Much of what's happening in the market reminds me of what happened in the late 1990s when market segments were bid up to levels based on future assumptions."

Because its price chart resembles that of the Nasdaq index of technology businesses from more than two decades ago, analogies to that period and the dot-com implosion that followed are becoming more common in discussions of ARK.

"Today marks the 253rd trading day from ARK's all-time high," Jessica Rabe, co-founder of DataTrek Research, wrote in a Tuesday note, "while the Nasdaq was down 60% from its dot-com bubble top on the same day in 2001."

"If 2000/2001 analog holds, we should see ARK continuing to fall over the following three weeks. The Nasdaq dropped 18.7% in the next 16 trading days "recent."

Net flows are positive.

The better news for investors and Ms. Wood is that there may be some immediate respite. The Nasdaq rose 41% in six weeks in 2001 before falling.

The ARK Investment Management did not respond to a request for comment.

Most of ARK's $US15 billion asset loss has been attributed to bad performance, a plus for the company. Since the fund achieved an intraday high of $US159.70 a year ago this week, investors have withdrawn only around $US465 million, and ARK's net flows this year are positive despite a more than 20% drop.

This exceptional loyalty prevents a worsening situation and allows Wood's approach to recovering. The star fund manager has consistently emphasized that her funds have a five-year investment horizon and that she believes in many good options.

Mr. Schutte, on the other hand, says the drop is understandable because several of the company's biggest bets, such as Teladoc and Zoom, are becoming less significant as COVID-19 approaches.

"During the pandemic, there were a lot of questions about what would happen to society and how we'd go about our lives," he added.

"You drew in new investors who wanted to know "what are the upcoming themes I should invest in?" I believe you got a washout of it as well."

On Friday, Cathie Wood sold $148.9 million worth of Palantir stock, halving her exposure.

Ark Investment Management, run by Cathie Wood, sold more Palantir Technologies Inc PLTR -6.39 percent shares on Friday, cutting its stake in the Peter Thiel-backed company.

According to Friday's closing price, the famous investment management firm sold 13.5 million shares of the big data company, valued at $148.9 million.

Palantir's stock fell 6.4 percent to $11.02 per share on Friday. The stock has lost 16% of its value in the last week.

Before Friday's trade, Ark Invest held 25.53 million shares in Palantir, suggesting that the famous stock picker had trimmed over 52 percent of its total keeping a day later.

After the business disclosed lower-than-expected fourth-quarter earnings before the market opened on Thursday, Ark Invest, located in St. Petersburg, California, dumped shares in Palantir for the second time.

The software firm, well-known for its work with government organizations, posted earnings of 2 cents per share, falling short of the analyst consensus of 4 cents. The company recorded quarterly revenues of $432.87 million, higher than the $417.69 million predicted by analysts.

Palantir's stock had been sold for 4.77 million shares by the investment firm the day before.

All six of Ark Invest's active exchange-traded funds own Palantir stock, including the flagship Ark Innovation ETF ARKK -4.88 percent.

Before the recent sell-off, Ark Invest had been stockpiling Palantir shares for months.

Cathie Wood appeared on television to defend her ARK funds' dismal performance. It didn't go quite as planned.

The Ark Innovation ETF (ARKK), Cathie Wood's flagship fund, is down 30% year to date and more volatile than almost any other fund on the market. On CNBC's Halftime Report, Wood jumped at the chance to defend the fund and its deflated price, which is currently $68.80, down from $155 a year ago.

"We've seen a significant decline," Wood said, adding, "We feel innovation is at bargain basement zone." Even though her ETF was underperforming, she emphasized that her companies were still "very inexpensive" and that the current fund loss was temporary. When the call's 40 free minutes were finished, Zoom gave her an extra 10 minutes to complete the interview.

Having Zoom check to see whether she was "running out of time?" Wood, who has been aggressively buying up shares in Zoom and other IT firms that have fallen from their pandemic highs, was unhappy. Zoom, like Wood's other significant tech holdings, Teladoc Health, Roku, and Roblox, is down 20% to 40% year to date as investors worry about rising interest and inflation rates.

However, a significant chunk of the interview was devoted to a personal assault on Cathie Wood, who was named the most excellent stock picker in 2020 by Bloomberg's then-Editor-in-Chief Matthew Winkler after correctly forecasting that Tesla will one day be valued at more than $1 trillion.

Wood bluntly ignored Tuttle Capital Management's Short Innovation ETF (SARK), which tracks the inverse performance of ARKK using swaps contracts for the sole purpose of betting against Cathie Wood's selections. "They're not conducting any research." She explained, "All they're doing is shorting innovation."

Of course, SARK is betting against Cathie Woods, not on innovation. "Well, we stand for invention," Wood responded. The SARK ETF has gained 55 percent since its debut, whereas the ARKK ETF has declined by 42 percent.

Tuttle Capital Management CEO Matthew Tuttle chimed in on the SARK ETF, calling it a "tool" for investors. According to SARK, "to convey a negative view of the market, innovative enterprises, the current rising rate environment, or a [specific] portfolio manager if they wish." "It's un-American not to have options in the marketplace," Tuttle told Insider on Thursday.

In any event, Wood is making progress. Her main concern currently is bearish calls on her ETF. "Our major concern is that our investors convert temporary losses into long-term losses," Wood continued.